Duality Biotherapeutics
$39.88
0
+$1.77+4.65%Friday 12:05
Statistics
Day High
-
Day Low
-
52W High
45.05
52W Low
39.88
Volume
-
Avg. Volume
391,800
Mkt Cap
3.63B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
Aug 28Expected
Q2 2025
Q4 2025
Q2 2026
-6.94
-5.12
-3.31
-1.5
Expected EPS
N/A
Actual EPS
-1.501236
Financials
-139.68%Profit Margin
Unprofitable260.57MRevenue
-363.97MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Operating as a clinical-stage enterprise, Duality Biotherapeutics, Inc. concentrates on pioneering next-generation antibody-drug conjugate (ADC) therapies and proprietary duality immune toxin antibody conjugate (ITAC) solutions. The firm was founded by Zhu Zhong Yuan on July 3, 2019, and its main offices are situated in Shanghai, China.
Show More
CEO
Zhongyuan Zhu
Employees
231
Country
China
ISIN
KYG2929M1087
WKN
000A414LZ
Listings
0 Comments
Share your thoughts
FAQs
What is Duality Biotherapeutics stock price today?▼
The current price of DUTBF is $39.88 USD — it has increased by +4.65% in the past 24 hours. Watch Duality Biotherapeutics stock price performance more closely on the chart.
What is Duality Biotherapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Duality Biotherapeutics stocks are traded under the ticker DUTBF.
Is Duality Biotherapeutics stock price growing?▼
DUTBF stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Duality Biotherapeutics has showed a +0% increase.
What is Duality Biotherapeutics market cap?▼
Today Duality Biotherapeutics has the market capitalization of 3.63B
When is the next Duality Biotherapeutics earnings date?▼
Duality Biotherapeutics is going to release the next earnings report on March 23, 2027.
What were Duality Biotherapeutics earnings last quarter?▼
DUTBF earnings for the last quarter are -1.5 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Duality Biotherapeutics revenue for the last year?▼
Duality Biotherapeutics revenue for the last year amounts to 260.57M USD.
What is Duality Biotherapeutics net income for the last year?▼
DUTBF net income for the last year is -363.97M USD.
How many employees does Duality Biotherapeutics have?▼
As of November 7, 2026, the company has 231 employees.
In which sector is Duality Biotherapeutics located?▼
Duality Biotherapeutics operates in the Health & Wellness sector.
When did Duality Biotherapeutics complete a stock split?▼
Duality Biotherapeutics has not had any recent stock splits.
Where is Duality Biotherapeutics headquartered?▼
Duality Biotherapeutics is headquartered in Shanghai, China.